(Q39266815)

10 September 2017

title

The long-term hypotensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A38623

1 November 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

1 November 2022

author name string

P. J. Airaksinen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A38623

1 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=38623

1 November 2022

publication date

1 June 1979

1 reference

full work available at URL

10 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.1979.tb01825.x

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.1979.tb01825.x/fullpdf

1 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

1 November 2022

1 reference

10 September 2017

volume

57

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

425-434

1 reference

Long-Term Experience with Timolol Ophthalmic Solution in Patients with Open-Angle Glaucoma

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.1979.TB01825.X

Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.1979.TB01825.X

The adrenergic receptors of the intraocular muscles of the human eye

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma

1 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

The treatment of glaucoma with propranolol (Inderal). A clinical trial

1 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Oculocutaneous reaction to oxprenolol

1 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Glaucoma treatment with timolol

1 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

The intraocular pressure response of glaucomatous eyes to topically applied bupranolol

1 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction

1 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Timolol. A new drug for management of chronic simple glaucoma

1 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Pathology of practolol-induced ocular toxicity

1 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

The effect of 1.5% timolol maleate on intraocular pressure

1 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Metoprolol eye drops in the treatment of glaucoma a double-blind single-dose trial of a beta1-adrenergic bloking drug

1 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Hypotensive effect of timolol on secondary glaucoma in chronic uveitis

1 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Effect of timolol therapy on outflow facility

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

Untoward effects associated with practolol administration: oculomucocutaneous syndrome

1 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1755-3768.1979.TB01825.X

1 November 2022

Identifiers

1 reference

10 September 2017

1 reference